Rise in prevalence of autoimmune diseases and chronic respiratory conditions, advent of new drugs, and surge in adoption rate of anti-inflammatory drugs drive the growth of the global anti-inflammatory therapeutics market. The Covid-19 pandemic positively affected the anti-inflammatory therapeutics market, as Covid-19 infection causes severe anti-inflammatory pneumonia, acute respiratory distress syndrome, multiple organ failure, and acute lung injury.
Portland, OR, July 21, 2021 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global Anti-Inflammatory Therapeutics Market was accounted for $98.02 billion in 2020, and is estimated to hit $125.55 billion by 2028, growing at a CAGR of 4.0% from 2021 to 2028.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/286
Rise in prevalence of autoimmune diseases and chronic respiratory conditions, advent of new drugs, and surge in adoption rate of anti-inflammatory drugs drive the growth of the global anti-inflammatory therapeutics market. However, side effects of anti-inflammatory drugs and patent expiration hinder the market growth. On the contrary, development of biosimilars for existing drugs is expected to open lucrative opportunities for the market players in the future.
The Covid-19 pandemic positively affected the anti-inflammatory therapeutics market, as Covid-19 infection causes severe anti-inflammatory pneumonia, acute respiratory distress syndrome, multiple organ failure, and acute lung injury.
The Covid-19 infection increased the investment in R&D for the treatment of inflammation in patients. Moreover, several clinical trials are underway to alleviate such inflammation in Covid-19 patients.
The report segments the global anti-inflammatory therapeutics market on the basis of drug class, indication, and region.
Based on drug class, the anti-inflammatory biologics segment held the lion’s share in 2020, accounting for nearly three-fifths of the market. Moreover, the segment is expected to register the highest CAGR of 4.3% during the forecast period. The research also analyzes the segments including nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/286
On the basis of indication, the Psoriasis segment would showcase the highest CAGR of 4.9% during the forecast period. However, the arthritis segment held the largest share in 2020, contributing to around two-fifths of the market.
The global anti-inflammatory therapeutics market is analyzed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America dominated in 2020, holding more than one-third of the market. However, the market across Asia-Pacific is expected to manifest the highest CAGR of 5.2% from 2021 to 2028.
The global anti-inflammatory therapeutics market report includes an in-depth analysis of the prime market players such as Abbvie, Inc., Pfizer, Inc., GlaxoSmithKline, Johnson & Johnson, Novartis, Merck & CO., Inc., La Roche AG, F. Hoffman, AstraZeneca PLC, Eli Lily and Company, and Amgen.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
CONTACT: Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 firstname.lastname@example.org Web: https://www.alliedmarketresearch.com Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research